Sunrise in melanoma management: Time to focus on melanoma burden in Asia-Reference-Cited by-同舟云学术

Sunrise in melanoma management: Time to focus on melanoma burden in Asia

Published:2017-02-15 Issue:6 Volume:13 Page:423-427
ISSN:1743-7555
Container-title:Asia-Pacific Journal of Clinical Oncology
language:en
Short-container-title:Asia-Pac J Clin Oncol

Author:

Chang John Wen-Cheng¹²,Guo Jun³,Hung Chia-Yen⁴,Lu Si³,Shin Sang Joon⁵,Quek Richard⁶,Ying Anthony⁷,Ho Gwo Fuang⁸,Nguyen Huu Sau⁹,Dhabhar Boman¹⁰,Sriuranpong Virote¹¹,Tiambeng Maria Luisa¹²,Prayogo Nugroho¹³,Yamazaki Naoya¹⁴

Affiliation:

1. Division of Hematology-Oncology; Department of Internal Medicine; Chang Gung Memorial Hospital at Linkou; Taoyuan Taiwan

2. Immune-Oncology Center of Excellence; Chang-Gung Memorial Hospital; Taipei Taiwan

3. Department of Renal Cancer and Melanoma; Peking University Cancer Hospital & Institute; Beijing China

4. Division of Hematology-Oncology; Department of Internal Medicine; Mackay Memorial Hospital; Taipei Taiwan

5. Yonsei Cancer Center; Yonsei University College of Medicine; Seoul South Korea

6. Division of Medical Oncology; National Cancer Centre Singapore; Singapore Singapore

7. Ying Chi Ho Anthony Clinic; Central Hong Kong

8. University Malaya Medical Centre; Kuala Lumpur Malaysia

9. National Hospital of Dermatology and Venereology; Hanoi Vietnam

10. Fortis Hospital; Mumbai India

11. Chulalongkorn University and the King Chulalongkorn Memorial Hospital; Bangkok Thailand

12. Cardinal Santos Cancer Center; Manila the Philippines

13. Dharmais National Cancer Center; Jakarta Indonesia

14. Department of Dermatologic Oncology; National Cancer Center Hospital; Tokyo Japan

Publisher

Wiley

Subject

Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ajco.12670/fullpdf

Reference43 articles.

1. Ferlay J Soerjomataram I Ervik M

2. Malignant melanoma in Taiwan: A prognostic study of 181 cases;Chang;Melanoma Res.,2004

3. Statistics for malignant melanoma in Japan: A nationwide survey from 2005 to 2013;Fujisawa;Skin Cancer (Japan).,2014

4. Clinical presentation, histology, and prognoses of malignant melanoma in ethnic Chinese: A study of 522 consecutive cases;Chi;BMC Cancer.,2011

5. Altekruse SF Kosary CL Krapcho M

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cutaneous Adverse Reactions and Survival Outcomes of Advanced Melanoma Treated with Immune Checkpoint Inhibitors in an Academic Medical Centre in Singapore;Diagnostics;2024-07-25

2. Treatment of acral and mucosal melanoma: Current and emerging targeted therapies;Critical Reviews in Oncology/Hematology;2024-01

3. Anatomic mapping of acral melanocytic nevi and acral lentiginous melanomas among Taiwanese patients: A retrospective cohort study;Journal of the Formosan Medical Association;2023-11

4. Survival rates for invasive cutaneous malignant melanoma in South Korea in accordance with the Eighth edition AJCC Cancer Staging Manual: A retrospective single center study;Indian Journal of Dermatology, Venereology and Leprology;2023-05-28

5. BRAF V600E Mutations and Beyond: A Molecular Perspective of Melanoma from a Tertiary Cancer Referral Center of India;South Asian Journal of Cancer;2023-03-02